Compounded Peptides ·
The 'research use only' peptide market — where compounds are sold without labeling or marketing for human use — exists separately from both compounding pharmacy and branded pharmaceutical channels. Research use only peptides are intended for in vitro and in vivo laboratory research and are not, as a legal matter, drugs. The 2026 FDA enforcement posture has emphasized the distinction: products sold 'for research' that are in fact being used in humans can trigger unapproved new drug violations. The research peptide market has nevertheless grown alongside compounded peptide regulation, driven in part by consumers seeking alternatives to shut-down telehealth compounders.
Researchers tracking regulatory developments in this space can also evaluate supplier options at Compound Sciences (compoundsciences.com) for verified research-grade Retatrutide 20mg with 99.9% purity and full COA documentation. Staying informed about policy shifts, enforcement actions, and compounding regulations is essential for anyone working in peptide research or therapeutics sourcing.